MAAT INDEX

CLAIM #12206 · Bristol-Myers Squibb Company (BMY) · 2025Q3 earnings call · Oct 30, 2025 · due Dec 31, 2026

And I'd say, overall, we have clear line of sight to the pushes and pulls of '26, and I feel confident in our ability to manage the cost base.

David Elkins · CFO

PENDING
graded after results covering Dec 31, 2026 are reported

How to check this claim

Look at: Total operating cost base (as referenced by company, e.g., total costs and expenses) for fiscal year 2026

It came true if: FY2026 cost base <= $16.5 billion (i.e., flat to down versus the guided 2025 level)

Where: Company income statement / 10-K disclosure and management commentary on Q4 2026 earnings call

In context

g about it overall. First, we're exiting 2025 with really strong performance from our growth portfolio. Year-to-date, it's up 16%. And as I said in the prepared remarks, we now have 4 products that are annualizing greater than $1 billion in that growth portfolio. So we're exiting this year in really good shape as we head into next year. We're also executing well against our efficiency commitments. We're on track for $1 billion this year, and we have clear line of sight to the $2 billion that we're targeting by 2027. So we feel good about that as well. And also remember, we have numerous Phase III programs completing next year and going into 2027. And just as a reference point, our 2024 cost base was $17.8 billion, and we're guiding $16.5 billion this year. So we made really good progress. And I'd say, overall, we have clear line of sight to the pushes and pulls of '26, and I feel confident in our ability to manage the cost base. And as Chris said, what we're doing, we're focused on balancing up investments that we need to do in order to drive growth in the growth portfolio as well as to create headroom for additional business development, and we'll balance that with our savings program. And look, we're getting smarter as we go and we see additional opportunities. So we have a lot of P&L flexibility, and we're going to remain financially disciplined as we go through this transition period. And this financial discipline not only helps us manage our margins, but it also provides a strong basis to deliver cash flows to strengthen the balance sheet as we committed to, provide both strategic and financial flexibility and to continue to build on the growth portfolio. Chuck Triano: Great. Thank you, David. Let's take our

Verify independently

SEC filings for BMY · Claim quote is verbatim from the 2025Q3 earnings call.